Bliss GVS Pharma board approves increase in foreign investment limit

The board has given its nod to increase FII/FDI limits from 24% to 74% in the company.

Feb 26, 2019 04:02 IST India Infoline News Service

Shares of Bliss GVS Pharma erased morning gains to trade flat on the BSE in morning trade on Tuesday. The company's board has given the green light to increase foreign institutional investment (FPI) and foreign direct investment (FDI) limits from 24% to 74%.

Bliss GVS Pharma Ltd share price is currently at Rs180.95, up Rs0.65, or 0.36%, from its previous close of Rs180.30 on the BSE. The scrip opened at Rs179.90 and has touched a high and low of Rs182 and Rs177.20,  respectively.

The BSE group 'B' stock of face value Rs1 has touched a 52-week-high of Rs224.70 on April 25, 2018, and a 52-week low of Rs125 on December 6, 2018. Last one week high and low of the scrip stood at Rs183 and Rs145.35, respectively.

Related Story